UBUS:F:F-UBS (Irl) ETF Public Limited Company - Factor MSCI USA Prime Value UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 31.65

Change

+0.31 (+0.97)%

Market Cap

USD 0.33B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-22 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.21 (+0.78%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.44 (+0.88%)

USD 115.04B
FRCJ:F UBS MSCI Japan Socially Respon..

+0.19 (+0.87%)

USD 83.57B
SXR8:F iShares Core S&P 500 UCITS ETF..

-2.29 (-0.46%)

USD 80.45B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.37 (+0.69%)

USD 76.57B
EUNL:F iShares Core MSCI World UCITS ..

-0.32 (-0.35%)

USD 72.04B
SXRZ:F iShares VII PLC - iShares Nikk..

+2.20 (+0.97%)

USD 58.19B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.10 (+0.67%)

USD 56.18B
VUSA:F Vanguard Funds Public Limited ..

-0.60 (-0.67%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.63 (-0.71%)

USD 49.95B

ETFs Containing UBUS:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.05% 71% C- 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.05% 70% C- 63% D
Trailing 12 Months  
Capital Gain 20.78% 81% B- 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 20.78% 80% B- 69% C-
Trailing 5 Years  
Capital Gain 59.99% 82% B 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 59.99% 81% B- 63% D
Average Annual (5 Year Horizon)  
Capital Gain 11.25% 86% B+ 79% B-
Dividend Return 11.25% 86% B+ 73% C
Total Return N/A 75% C 96% N/A
Risk Return Profile  
Volatility (Standard Deviation) 16.31% 33% F 66% D+
Risk Adjusted Return 69.00% 92% A 91% A-
Market Capitalization 0.33B 52% F 45% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.